Open Nav

Wednesday, November 13, 2013, 3:30 p.m. - 4:25 p.m, Room 403

This panel will look at current opportunities for global biotech transfer in China, what development funds are available, and how they promote the development of the industry.


• Samantha Du, Managing Director, Sequoia Capital China

• Syd Hanna, Partner, Elixir Ventures

• Simon Harworth, CEO, Dynasty Biotechnology Limited

• Dave Tapolczay, CEO, Medical Research Council Technology